The #BiotechRevolution: Innovation with Purpose in the Age of Disruption
This article, written by Joaquín Gómez Moya, our Executive President, offers #keyinsights into the challenges and opportunities shaping the #biotechsector today.
You can read the full piece here: The Biotech Revolution: Navigating Innovation with Purpose in the Age of Disruption.
In #biotechnology, success isn’t solely about scientific breakthroughs. It’s about navigating a complex market, managing ethical and technological risks, and aligning teams around a clear purpose. The article highlights critical lessons we’ve learned at #VivaInVitro, such as:
💡 Active #marketengagement: Our experience with VIVA ELISA® illustrates that true innovation comes from addressing real unmet needs, like the critical challenges in #sepsis management.
💡 Aligned teams with a #sharedpurpose: The synergy between scientific leadership, headed by Dr. Pablo Pelegrin, and strategic business direction, led by Toni Vilaplana Vivancos, drives exponential growth and innovation.
💡 Proactive #riskmanagement: Transparency and robust protocols are essential in building trust with regulators, investors, and clinicians, especially in a sector where risks extend beyond the technical to ethical and practical dimensions.
The article also delves into the future of #biotech: leveraging emerging technologies like quantum computing and #generativeAI while staying anchored in ethical values and designing solutions with simplicity and impact.
Supported by the #EICTransition program and recognized as one of Europe’s 40 most disruptive companies, we remain committed to our vision: leading from Europe toward a future where innovation transforms lives.
#SomosBiotecnologia #WeAreBiotechnology
Operations | Project Management | Program Management | Startups | Management Consulting
3moTrue true. Massachusetts is building on all fronts , depth and breadth making it an extremely competitive innovation ecosystem nationally and globally.